Listing of Noveko International Inc.'s Shares on the Toronto Stock Exchange



    EKO / TSX

    MONTREAL, July 28 /CNW Telbec/ - Noveko International Inc. ("Noveko" or
the "Corporation") is pleased to announce that its Class A Shares will be
posted for trading on the Toronto Stock Exchange at the opening of business
today, July 28, 2008, under the ticker symbol EKO - the same symbol used when
its shares were traded on the TSX Venture Exchange.

    Appointment of Alain Falardeau LL.B. as the Corporation's Vice-President,
    Legal Affairs

    Noveko is also pleased to announce the appointment of Alain Falardeau to
the newly created position of Vice-President, Legal Affairs. Mr. Falardeau has
over twenty years' experience in commercial law, more specifically in all
aspects of securities law, corporate financing and business acquisitions. He
was previously senior counsel with Marchand Melançon Forget, a Montreal law
firm.
    "Noveko's current and future growth requires a strong, cohesive
management team, and Mr. Falardeau will make an excellent addition to our
group, given his expertise and his solid experience in commercial law. In
addition, Mr. Falardeau knows Noveko well, since he has acted as our external
legal advisor for several years. We are very pleased that he is joining our
team," indicated André Leroux, Chairman and Chief Executive Officer of Noveko.

    Stock Option Grants

    Noveko's Board of Directors granted options to some of the group's
employees, allowing them to acquire a total of 350,000 Class A shares of
Noveko, at a unit price of $3.52, subject to the terms of Noveko's Stock
Option Plan.

    Profile
    -------

    Noveko International Inc. is a public holding company. Currently, its
operating subsidiaries are S.A.S. ECM, Noveko Inc., Laboratoire SyMa Inc.,
Bolduc Leroux Inc., Magnum Pharmaceutics Inc., Unitam International Management
Corporation Inc., Noveko Algérie and Groupe Conseils Micron-Air inc. ECM
specializes in portable real-time ultrasound scanners for veterinary and human
medicine. Noveko Inc. develops biomedical and environmental products derived
from its patented antimicrobial filtration technology (Noveko(TM)
antimicrobial face masks and air filters). SyMa specializes in sanitizers,
sold under the Azuro(TM) brand. Magnum acts as a manufacturer sales agent for
the Noveko Group's biomedical and environmental products and sanitizers and
for other manufacturers. Unitam is an international business development
service agency established in North America and Asia. Noveko Algérie is a
medical equipment import company covering the Maghreb and Middle East markets.
Micron-Air inc. is a designer and manufacturer of air quality systems marketed
under the EPURAIR(TM) brand and targeted to the residential market. Lastly,
BLI is involved in the custom processing and distribution of steel products
based on client specifications.

    The information set forth in this press release includes certain
forward-looking statements. Such statements are based on assumptions exposed
to major risks and uncertainties. Although Noveko deems the expectations
reflected in these forward-looking statements to be reasonable, the Company
cannot provide any guarantee as to the materialization of the expectations
reflected in these forward-looking statements. The TSX Venture Exchange and
the Toronto Stock Exchange have not reviewed and do not accept responsibility
for the adequacy or accuracy of this release.




For further information:

For further information: André Leroux, Chairman of the Board and Chief
Executive Officer; Alain Bolduc, President and Chief Operating Officer, Noveko
International Inc., (514) 344-3030; http://www.noveko.com

Organization Profile

Noveko International Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890